Literature DB >> 8961156

Comparative study of separation of non-encapsulated drug from unilamellar liposomes by various methods.

S R Dipali1, S B Kulkarni, G V Betageri.   

Abstract

The purpose of this study was to compare the various methods available to separate non-encapsulated drug from large unilamellar liposomes (LUV). Multilamellar liposomes (MLV) were prepared by thin film hydration using distearoylphosphatidylcholine:cholesterol (2:1 molar ratio). MLVs were passed through a 0.2 micron polycarbonate membrane using an extruder to prepare LUVs. Particle size of liposome preparations was characterized using a submicron particle-size analyser. The non-encapsulated drug was separated by: filtering through Centrifree tubes; passing through gel (Sepharose-4B and Sephadex G-25M); passing through minicolumn; ficoll density gradient; protamine aggregation; or dialysis. The dialysis method was found to be unsuitable for separation of non-encapsulated drug due to equilibration of encapsulated drug as the free drug was dialyzed. The upper limit for lipid concentration was 5 mg mL-1 using the Centrifree method. Separation using gel chromatography led to dilution of liposome preparation. Minicolumn and density gradient techniques did not lead to sample dilution, however the minicolumn method was tedious. The time required for separation of liposomes by protamine aggregation was longer for neutral liposomes. Thus it was concluded that the Centrifree was the fastest method to estimate encapsulation; the density gradient method was ideal to separate non-encapsulated drug; and protamine aggregation was the least expensive method to estimate encapsulation efficiency.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8961156     DOI: 10.1111/j.2042-7158.1996.tb03904.x

Source DB:  PubMed          Journal:  J Pharm Pharmacol        ISSN: 0022-3573            Impact factor:   3.765


  9 in total

1.  Liposomes as a model for the biological membrane: studies on daunorubicin bilayer interaction.

Authors:  Carla Matos; Carla Moutinho; Paulo Lobão
Journal:  J Membr Biol       Date:  2012-01-01       Impact factor: 1.843

Review 2.  Chapter 10: Infrared and Raman microscopy in cell biology.

Authors:  Christian Matthäus; Benjamin Bird; Milos Miljković; Tatyana Chernenko; Melissa Romeo; Max Diem
Journal:  Methods Cell Biol       Date:  2008       Impact factor: 1.441

Review 3.  Rate of solute incorporation to liposomes evaluated from encapsulated enzymes activities.

Authors:  Manuel Ahumada; Cristian Calderón; Luis León; Eduardo Lissi
Journal:  Biophys Rev       Date:  2014-02-11

4.  New ways of imaging uptake and intracellular fate of liposomal drug carrier systems inside individual cells, based on Raman microscopy.

Authors:  Christian Matthäus; Amit Kale; Tatyana Chernenko; Vladimir Torchilin; Max Diem
Journal:  Mol Pharm       Date:  2008-01-16       Impact factor: 4.939

5.  Characterization and in vivo evaluation of novel lipid-chlorambucil nanospheres prepared using a mixture of emulsifiers for parenteral administration.

Authors:  Honglin Song; Shufang Nie; Xinggang Yang; Ning Li; Hongtao Xu; Liangyuan Zheng; Weisan Pan
Journal:  Int J Nanomedicine       Date:  2010-11-09

6.  Development and stability studies of novel liposomal vancomycin formulations.

Authors:  Krishna Muppidi; Andrew S Pumerantz; Jeffrey Wang; Guru Betageri
Journal:  ISRN Pharm       Date:  2012-01-26

7.  A dual-mediated liposomal drug delivery system targeting the brain: rational construction, integrity evaluation across the blood-brain barrier, and the transporting mechanism to glioma cells.

Authors:  Chang Liu; Xiao-Na Liu; Gui-Ling Wang; Yu Hei; Shuai Meng; Ling-Fei Yang; Lan Yuan; Ying Xie
Journal:  Int J Nanomedicine       Date:  2017-03-28

8.  Characterization and Pharmacokinetic Evaluation of Oxaliplatin Long-Circulating Liposomes.

Authors:  Nihad Cheraga; Ammar Ouahab; Yan Shen; Ning-Ping Huang
Journal:  Biomed Res Int       Date:  2021-04-20       Impact factor: 3.411

9.  Folate receptor-targeted liposomes loaded with a diacid metabolite of norcantharidin enhance antitumor potency for H22 hepatocellular carcinoma both in vitro and in vivo.

Authors:  Min-Chen Liu; Lin Liu; Xia-Rong Wang; Wu-Ping Shuai; Ying Hu; Min Han; Jian-Qing Gao
Journal:  Int J Nanomedicine       Date:  2016-04-04
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.